Overview of Dextrose 5%

Property	Description
Active Ingredient	Dextrose (D-glucose)
Form	Sterile Solution for Intravenous Infusion
Pharmacological Class	Fluid and Nutrient Replenisher / Caloric Agent
Common Use	Hydration and Minimal Energy Provision
Origin	Naturally Derived Simple Sugar

Dextrose 5% in Water, widely known as D5W, is a sterile solution for intravenous infusion used to provide essential fluid and a basic source of energy directly into the bloodstream. This formulation is clinically recognized across health systems as a Fluid and Nutrient Replenisher and a Caloric Agent designed exclusively for parenteral (intravenous) administration when a patient cannot take fluids or energy orally.

What Type of Medicine is Dextrose 5%? (D5W Identity and Classification)

Dextrose 5% is a crystalloid solution containing the active ingredient, Dextrose (D-glucose), a simple sugar naturally derived from carbohydrate sources. It is provided as a single-ingredient product dissolved in Sterile Water for Injection. The 5% concentration signifies five grams of dextrose per 100 milliliters of water. This specific composition makes the solution an effective provider of free water.

The INN formulation's distinct feature is its functional role: it becomes a source of "free water" after the body rapidly metabolizes the dextrose component. This action is distinct from standard isotonic saline solutions, which are primarily designed to remain within the vascular space.

What is the General Purpose of Dextrose 5%?

The general purpose of Dextrose 5% is to provide minimal, immediate caloric support and facilitate systemic hydration. By supplying D-glucose, the solution ensures that basic energy needs are met, helping to prevent the body from utilizing its own protein stores for fuel. This function is essential for maintaining fluid balance and preventing simple water depletion.

Beyond its role as a nutrient replenisher, D5W frequently serves as a neutral vehicle for medication. Its stable, sterile nature allows it to be widely used to safely dilute and deliver many other injectable drugs, ensuring precise administration into the patient's system.

Regulatory References

NIH Classification

What side effects are possible with Dextrose 5%?

Possible Side Effects and Safety Information

The safety profile for Dextrose 5% Intravenous Solution is primarily derived from governmental regulatory documents, focusing on potential imbalances and administration site reactions.

Adverse Reactions by Category

Adverse reactions associated with Dextrose 5% are classified by regulatory agencies based on their effect on body systems and may include:

System-Organ Class	Examples of Documented Reactions
Metabolism and Nutrition Disorders	Hyperglycemia (high blood sugar), Hyponatremia (low blood sodium), and general electrolyte imbalance
General Disorders and Administration Site Conditions	Infection, pain, venous thrombosis or phlebitis (vein inflammation) at the injection site, and fever (febrile response)
Immune System Disorders	Hypersensitivity reactions

Serious Adverse Reactions and Safety Constraints

Although rare, clinically significant adverse events are officially documented. These include Acute Hyponatremic Encephalopathy (brain swelling due to severe low sodium) and the risk of Intracerebral Hemorrhage in very low birth weight infants, particularly following rapid or excessive administration.

Safety Restrictions: Dextrose 5% must not be administered simultaneously with blood products through the same line due to the risk of pseudoagglutination or hemolysis of red blood cells. Caution is also required in patients with known corn allergies, diabetes, or those at high risk for fluid overload or hyponatremia.

Population-Specific Warnings

Official labels define specific precautions for certain groups:

Pediatrics (Especially Neonates): Requires close monitoring of blood glucose and volume due to heightened risk of hypoglycemia, hyperglycemia, and fluid-related complications.
Older Adults: May be more susceptible to fluid overload and electrolyte disturbances due to generally decreased renal function.

This information is strictly descriptive of the regulatory safety documentation and does not include dosage, therapeutic uses, or clinical advice.

Overdose and Emergency Response

The official regulatory profile for Dextrose 5% overdose is defined by the consequences of administering the solution at a rate or volume that exceeds the body's capacity for glucose utilization and fluid homeostasis. This can result in two primary documented forms of overload.

Documented Overdose Presentations

Metabolic and Solute Overload: Manifests as hyperglycemia (high blood sugar) and a hyperosmolar state.
Fluid and Electrolyte Imbalance: Characterized by hypervolemia (fluid overload), dilutional hyponatremia (low serum sodium), pulmonary congestion, and edema.

Severe Outcomes and Emergency Action

Severe, life-threatening outcomes are explicitly documented. These include acute symptomatic hyponatremic encephalopathy and cerebral edema, which may progress to seizures, coma, and death. Individuals must seek immediate medical attention when signs of these severe central nervous system (CNS) effects or pulmonary congestion appear.

The required emergency action, as stated in regulatory documents, is to discontinue the infusion immediately upon evidence of overdosage. Management is symptomatic and corrective, mandating close, frequent monitoring of serum sodium and blood glucose concentrations. Children, the elderly, and premenopausal women are cited as being at a particular risk for severe hyponatremic encephalopathy.

Therapeutic Uses of Dextrose 5%

What Dextrose 5% Treats: Main Uses and Benefits

Dextrose 5% injection is commonly used as a parenteral solution for fluid replenishment and minimal carbohydrate calories.

Dextrose 5% is relevant for easing symptoms of pure water loss, such as intense thirst, decreased urination, and fatigue resulting from low fluid volume. It also plays a role in managing acute manifestations of low blood sugar (hypoglycemia), such as confusion or lethargy, by supplying readily available glucose. Clinically, it is applied in addressing maintenance fluid therapy, providing essential energy, and supporting the patient when unable to eat or drink (NPO status).

The solution is also commonly used as a sterile, neutral vehicle for medication, allowing for the controlled dilution and delivery of numerous other compatible injectable drugs, which is relevant in postoperative care.

“The provision of basic energy support and hydration may assist with maintaining functional stability when symptoms are more noticeable.”

Quick Fact: Relief for Energy Deficits Dextrose 5% is used for managing minimal caloric input, which helps address the need for basic energy and contributes to easing the overall symptom load associated with energy deprivation.

Regulatory References

NIH DailyMed Drug Label for Dextrose Injection

Eligibility and Restrictions for Use

Dextrose 5% Injection (D5W) eligibility is strictly defined by regulatory authorities, focusing on a patient's metabolic and fluid status.

Contraindicated Populations (Must Not Use)	Conditional Use (Requires Caution/Monitoring)
Clinically significant hyperglycemia	Renal, Cardiac, or Pulmonary failure (risk of fluid/solute overload)
Known hypersensitivity to dextrose or corn products	Diabetes mellitus (risk of worsening hyperglycemia)
Simultaneous administration with blood (risk of pseudoagglutination)	Pediatric patients, especially neonates and low birth weight infants (risk of glucose instability and hyponatremia)
Severe dehydration (select labels)	Older adults (greater risk of decreased organ function)

D5W is an established therapy for adults and children but requires specialized caution in vulnerable groups. Use during pregnancy is categorized as Category C, meaning it should only be given if clearly needed. Nursing mothers are advised to use caution, as it is unknown if Dextrose is excreted in human milk. Patients with severe malnutrition or thiamine deficiency also require restricted use and close monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Dextrose 5% primarily details interactions related to fluid balance, physical compatibility, and procedural constraints during co-administration.

Documented Interaction Constraints

Interaction Domain	Official Restriction or Constraint
Blood Products	Do not administer simultaneously with blood products through the same infusion set to avoid the risk of pseudoagglutination or hemolysis.
Drugs Associated with Hyponatremia	Concomitant use with medicines that increase the risk of hyponatremia (such as diuretics) may heighten the risk of developing hyponatremia; use should be avoided in these patients where feasible.
Chemotherapy Agents	Specific diluent containers of Dextrose 5% are explicitly restricted and must not be used with chemotherapy agents.
Additives/Other Medicines	Consult a pharmacist for compatibility before introducing any additives; solutions containing additives must be prepared using aseptic technique, mixed thoroughly, and must not be stored.

These constraints establish the product's official interaction profile, focusing on maintaining safe administration practices and managing significant pharmacodynamic risks, such as serious electrolyte imbalance, rather than metabolic drug-drug interactions. The key regulatory emphasis is on avoiding specific co-administration procedures and managing the elevated risk of hyponatremia with certain concomitant medications.

Mechanism of Action

Dextrose 5% (D5W) introduces D-glucose molecules into the systemic circulation. Following intravenous administration, the glucose rapidly distributes across the extracellular and intracellular compartments. The primary biological targets are ubiquitous glucose transporters ( GLUTs), particularly GLUT1, GLUT3, and GLUT4, which facilitate the carrier-mediated movement of D-glucose down its concentration gradient into cells, functioning as a non-receptor substrate for transmembrane transport.

Within the cell, D-glucose is phosphorylated by hexokinase or glucokinase to glucose-6-phosphate. This phosphorylation serves as the first committed step in glycolysis, a molecular pathway that yields adenosine triphosphate ( ATP) via substrate-level phosphorylation and subsequent oxidative phosphorylation in the mitochondria. Glucose-6-phosphate also enters the pentose phosphate pathway and glycogenesis pathway. The downstream cascades include the generation of ATP from metabolic intermediates ( pyruvate) and the production of NADPH for reduction reactions. System-level physiological consequences involve a transient increase in plasma glucose concentration and subsequent cellular uptake, which provides a readily available source of substrate for cellular energy production and metabolic processes throughout the body, including the central nervous system which is obligately dependent on glucose as its primary fuel.

Dosage and Administration Information

How to Use Dextrose 5%

The administration of Dextrose 5% in Water (D5W) is governed by procedural principles defining its use as a sterile solution for fluid and minimal energy provision.

Administration Scope

The solution is for Intravenous (IV) Infusion only, typically administered through a peripheral vein for the 5% concentration. Dosage is individualized, with general adult volumes ranging from 500 mL to 3 L over 24 hours. The infusion rate is critical; it must be carefully controlled and should not exceed 5 mg of dextrose per kg of body weight per minute. This maximum rate is intended to align administration with the body's glucose oxidation capacity.

Classification Property	Classification
Administration Method Type	Intravenous (IV) Infusion
Frequency Pattern	Continuous Infusion (As required for support)
Use-Context Constraints	Aseptic administration, rate limitation, non-simultaneous administration with blood

Procedural Administration Rules

Before administration, the solution must be visually verified to be clear and colorless, with the container's seals intact. Dextrose 5% is widely used as a sterile vehicle to dilute and deliver compatible medications; in such cases, drug additives must be introduced aseptically. A critical procedural rule mandates that the flexible container must not be connected in series (tandem) to another fluid container, a constraint designed to prevent the risk of air embolism. Furthermore, the solution is not to be administered simultaneously with blood products through the same IV line due to the risk of incompatibility. For pediatric and older adult patients, it is recognized that dose selection and infusion rates should be approached with caution.

Recent Clinical Evidence

Dextrose 5%: Recent Clinical Evidence

Core Therapeutic Role

Clinical evidence consistently supports the use of Dextrose 5% in Water (D5W) primarily as a source of water and calories (carbohydrates) for patients who require intravenous fluid replacement or nutritional support. Because it is isotonic to plasma, D5W helps restore fluid balance and provides approximately 170 kilocalories per liter.

Applications in Fluid and Glucose Management

Recent clinical trials have explored D5W's role in specific care settings:

Hypoglycemia: Although higher concentration dextrose solutions (e.g., D10W, D50W) are typically reserved for immediate, acute hypoglycemia correction, D5W is commonly utilized for maintenance therapy to prevent blood sugar from dropping once the acute episode is resolved. Studies confirm its role in providing a steady glucose infusion.
Fluid Replacement: In the treatment of acute, non-hospitalized dehydration (such as from gastroenteritis), systematic reviews have examined whether adding dextrose to standard intravenous saline solutions improves outcomes like reducing hospital admission rates. Current evidence suggests that the addition of Dextrose 5% to saline has not been shown to provide an important benefit over saline alone in this specific population, but the possibility of clinical benefit remains under investigation.

Emerging Research Areas

Studies have also explored Dextrose 5% in the context of localized perineural injection therapy for chronic pain conditions, such as carpal tunnel syndrome (CTS). A systematic review and meta-analysis comparing D5W injections to corticosteroid injections for mild to moderate CTS noted that D5W injections were associated with a statistically significant improvement in functional status within three months and demonstrated fewer adverse effects. Further research is ongoing to fully define the efficacy and safety of this specialized application.

Frequently Asked Questions (FAQ)

Common questions about Dextrose 5% (FAQ)

Q: Can Dextrose 5% cause swelling or fluid retention?

Regulatory documents indicate that excessive administration of Dextrose 5% can lead to hypervolemia, which is an excess of fluid volume in the body. Possible documented reactions may include fluid collection in the lungs (pulmonary edema) or generalized congested states. Official guidance emphasizes that the rate of administration must be carefully controlled, as rapid or excessive infusion is associated with the risk of fluid overload.

Q: Is Dextrose 5% used in children or infants?

Official information confirms that Dextrose 5% is used in the pediatric population, including infants. However, due to their unique fluid and metabolic needs, official guidance strongly mandates special caution and close monitoring of blood sugar and fluid volume when the solution is administered to neonates, especially those of low birth weight.

Q: Can people with certain food allergies still receive Dextrose 5%?

Regulatory documents specify that Dextrose 5% may be contraindicated (must not be used) in people with a known hypersensitivity or allergy to corn products, as the dextrose used in the solution is typically derived from corn. Consultation with a healthcare provider is necessary if a corn allergy is known.

Q: What is the risk of high blood sugar (hyperglycemia) from Dextrose 5%?

Since Dextrose 5% provides glucose (a sugar), official warnings state that its infusion can cause hyperglycemia, or high blood sugar. This risk is notably higher for patients who have pre-existing conditions like diabetes or who have impaired glucose tolerance. Official documents indicate that close monitoring of blood sugar levels is typically utilized as a precaution during administration.

Q: How long does Dextrose 5% stay in your system?

Official documents describe Dextrose as being readily metabolized by the body. The dextrose component is quickly oxidized to carbon dioxide and water, providing energy. The maximum rate of infusion is established to align with the body’s natural capacity for glucose oxidation.

Q: Can Dextrose 5% interact with blood pressure medications?

Official drug interaction information focuses on managing fluid and electrolyte risks. Regulatory documents caution that solutions containing sodium, which may be included if the solution is used as a vehicle for additives, should be used carefully in patients taking certain medicines like corticosteroids or corticotropin, which can affect the body's fluid and blood pressure balance.

Q: Are there any long-term effects associated with receiving Dextrose 5%?

Official studies on Dextrose 5% have not been performed to evaluate potential long-term effects on carcinogenic potential, mutagenic potential, or fertility impairment. Official documents describe the product as being a source of water and carbohydrate.

Q: Does Dextrose 5% contain any electrolytes?

According to the official product description, Dextrose 5% Injection, USP is designed as a simple solution, containing only dextrose and sterile water for injection. It is explicitly described as a potassium-free and electrolyte-free solution.

Q: Why is Dextrose 5% sometimes called 'sugar water'?

The nickname is derived from the product's basic composition. Official regulatory descriptions identify Dextrose as a simple sugar, or hexose sugar, that is dissolved in Water for Injection. This factual description aligns with the common vernacular term.

Q: How quickly does Dextrose 5% start working after it's administered?

Official pharmacological documents state that Dextrose 5% is a source of water and carbohydrate that is readily metabolized by the body. Once administered intravenously, the glucose becomes quickly available to cells to support immediate metabolic processes.

Q: What happens if Dextrose 5% is given too fast?

Official warnings state that excessive or rapid administration can lead to serious consequences, including generalized fluid and/or solute overloading. For vulnerable groups like very low birth weight infants, rapid administration is specifically linked to the risk of intracerebral hemorrhage (bleeding in the brain).

Q: What is the difference between Dextrose 5% and Lactated Ringer's solution?

Dextrose 5% (D5W) is a simple solution containing only dextrose in water, used for hydration and minimal calories. In contrast, Lactated Ringer's is a solution that contains multiple electrolytes, including sodium, potassium, calcium, chloride, and lactate, and is primarily used to restore fluid and electrolyte balances.

Q: Does Dextrose 5% cause weight gain?

Official information is focused on the immediate clinical use. It is noted that Dextrose 5% provides minimal carbohydrate calories, roughly 170 kilocalories per liter. Regulatory documents do not address the product's effect on long-term body weight changes.

Q: Does Dextrose 5% carry a risk of bacterial contamination, and how is that prevented?

Official labels warn that documented reactions may include infection at the site of injection, indicating a contamination risk exists if protocols are not followed. Official labels specify that prevention involves the mandatory use of aseptic technique (sterile procedures) during administration and the requirement to inspect the solution and container prior to use.

Q: Is Dextrose 5% considered a hypertonic or hypotonic solution?

Dextrose 5% Injection, USP, is officially described as having an osmolarity of 252 mOsmol/L (calculated). This concentration means it is slightly hypotonic (lower solute concentration) compared to normal body fluids.

Q: Can Dextrose 5% be given to someone who is fasting?

Yes, Dextrose 5% is often used as a source of water and carbohydrate for patients who are unable to take fluids or energy orally, such as those who are fasting. However, caution is advised, and for certain fasting patients with good renal function, official documentation notes they may require supplemental potassium.

Q: Has there been recent research on new uses for Dextrose 5%?

Yes, recent evidence has examined Dextrose 5% in specific applications outside its primary role as a fluid and calorie source. For example, studies have collected evidence on its use in localized perineural injection therapy for chronic pain conditions, such as carpal tunnel syndrome.

Q: Does Dextrose 5% provide meaningful calories or nutrition?

Dextrose 5% Injection, USP is classified as a caloric agent and provides minimal nutritional support, specifically offering approximately 170 kilocalories per liter. While it provides immediate glucose energy, it is not considered a complete source of nutrition.

Q: Is Dextrose 5% available as a pill or only as an IV solution?

The official product, Dextrose 5% Injection, USP, is a sterile solution formulated exclusively for intravenous administration. It is not manufactured or available for use as an oral tablet or pill.

Q: How does Dextrose 5% affect the body's water balance?

The solution is a source of water and carbohydrate. Once the dextrose component is metabolized by the body, the remaining water acts as a source of 'free water' that can move easily between body fluid compartments. Official warnings state that excessive administration may lead to overhydration or the dilution of serum electrolyte concentrations.

Q: What evidence exists regarding the use of Dextrose 5% in the elderly?

Official guidance includes specific precautions for geriatric use. It advises that dose selection and infusion rates for older adults should be cautious, as this population has a greater frequency of decreased organ function (hepatic, renal, or cardiac), which can affect fluid and glucose metabolism.

How should Dextrose 5% be stored and disposed of?

Storage and Disposal Conditions for Dextrose 5% Injection

Dextrose 5% Injection, USP, must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). It is mandatory to Protect from freezing and avoid excessive heat during storage. The container must remain in its overwrap until use, and the solution must be clear and undamaged prior to administration.

Stability and Disposal

As this is a single-dose container, any unused portion must be discarded. Solutions that have had other medications added must not be stored and should be used immediately. All disposal of the product and its residues must adhere to local authority requirements for waste handling.

Dextrose 5%